These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 19910645)

  • 1. Estimating influenza vaccine effectiveness using routinely collected laboratory data.
    Fleming DM; Andrews NJ; Ellis JS; Bermingham A; Sebastianpillai P; Elliot AJ; Miller E; Zambon M
    J Epidemiol Community Health; 2010 Dec; 64(12):1062-7. PubMed ID: 19910645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza-attributable burden in United Kingdom primary care.
    Fleming DM; Taylor RJ; Haguinet F; Schuck-Paim C; Logie J; Webb DJ; Lustig RL; Matias G
    Epidemiol Infect; 2016 Feb; 144(3):537-47. PubMed ID: 26168005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of giving influenza vaccination to general practitioners: a controlled trial [NCT00221676].
    Michiels B; Philips H; Coenen S; Yane F; Steinhauser T; Stuyck S; Denekens J; Van Royen P
    BMC Med; 2006 Jul; 4():17. PubMed ID: 16831228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex disease dynamics and the design of influenza vaccination programs.
    Riley S
    PLoS Med; 2013 Nov; 10(11):e1001553. PubMed ID: 24260027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of seasonal influenza vaccine in preventing medically attended influenza infection in England and Wales during the 2010/2011 season: a primary care-based cohort study.
    Kafatos G; Pebody R; Andrews N; Durnall H; Barley M; Fleming D
    Influenza Other Respir Viruses; 2013 Nov; 7(6):1175-80. PubMed ID: 24103037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.
    Whitaker HJ; Willam N; Cottrell S; Goudie R; Andrews N; Evans J; Moore C; Agrawal U; Hassell K; Gunson R; Zitha J; Anand S; Sebastian-Pillai P; Kalapotharakou P; Okusi C; Hoschler K; Jamie G; Kele B; Hamilton M; Couzens A; Quinot C; Pheasant K; Byford R; Marsh K; Robertson C; de Lusignan S; Williams C; Zambon M; McMenamin J; Watson CH
    Influenza Other Respir Viruses; 2024 May; 18(5):e13295. PubMed ID: 38744684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resource use and direct medical costs of acute respiratory illness in the UK based on linked primary and secondary care records from 2001 to 2009.
    Meier GC; Watkins J; McEwan P; Pockett RD
    PLoS One; 2020; 15(8):e0236472. PubMed ID: 32760071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology.
    Chua H; Feng S; Lewnard JA; Sullivan SG; Blyth CC; Lipsitch M; Cowling BJ
    Epidemiology; 2020 Jan; 31(1):43-64. PubMed ID: 31609860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End of season influenza vaccine effectiveness in adults and children in the United Kingdom in 2017/18.
    Pebody R; Djennad A; Ellis J; Andrews N; Marques DFP; Cottrell S; Reynolds AJ; Gunson R; Galiano M; Hoschler K; Lackenby A; Robertson C; O'Doherty M; Sinnathamby M; Panagiotopoulos N; Yonova I; Webb R; Moore C; Donati M; Sartaj M; Shepherd SJ; McMenamin J; de Lusignan S; Zambon M
    Euro Surveill; 2019 Aug; 24(31):. PubMed ID: 31387673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of increased influenza vaccination in 2-3-year-old children on disease burden within the general population: A Bayesian model-based approach.
    Rajaram S; Wiecek W; Lawson R; Blak BT; Zhao Y; Hackett J; Brody R; Patel V; Amzal B
    PLoS One; 2017; 12(12):e0186739. PubMed ID: 29244811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End-of-season influenza vaccine effectiveness in adults and children, United Kingdom, 2016/17.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Gallagher N; Sinnathamby M; Yonova I; Correa A; Moore C; Sartaj M; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2017 Nov; 22(44):. PubMed ID: 29113630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RCGP Research and Surveillance Centre: 50 years' surveillance of influenza, infections, and respiratory conditions.
    de Lusignan S; Correa A; Smith GE; Yonova I; Pebody R; Ferreira F; Elliot AJ; Fleming D
    Br J Gen Pract; 2017 Oct; 67(663):440-441. PubMed ID: 28963401
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results.
    Pebody R; Warburton F; Ellis J; Andrews N; Potts A; Cottrell S; Johnston J; Reynolds A; Gunson R; Thompson C; Galiano M; Robertson C; Byford R; Gallagher N; Sinnathamby M; Yonova I; Pathirannehelage S; Donati M; Moore C; de Lusignan S; McMenamin J; Zambon M
    Euro Surveill; 2016 Sep; 21(38):. PubMed ID: 27684603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model-based reconstruction of an epidemic using multiple datasets: understanding influenza A/H1N1 pandemic dynamics in Israel.
    Yaari R; Katriel G; Stone L; Mendelson E; Mandelboim M; Huppert A
    J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27030041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP).
    Klett-Tammen CJ; Krause G; Seefeld L; Ott JJ
    BMC Public Health; 2016 Feb; 16():121. PubMed ID: 26846202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the elderly- and risk-group programme of vaccination against seasonal influenza in England and Wales: a cost-effectiveness study.
    Baguelin M; Camacho A; Flasche S; Edmunds WJ
    BMC Med; 2015 Oct; 13():236. PubMed ID: 26459265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination.
    Grijalva CG; Zhu Y; Williams DJ; Self WH; Ampofo K; Pavia AT; Stockmann CR; McCullers J; Arnold SR; Wunderink RG; Anderson EJ; Lindstrom S; Fry AM; Foppa IM; Finelli L; Bramley AM; Jain S; Griffin MR; Edwards KM
    JAMA; 2015 Oct; 314(14):1488-97. PubMed ID: 26436611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons.
    Su WJ; Chan TC; Chuang PH; Liu YL; Lee PI; Liu MT; Chuang JH
    Int J Infect Dis; 2015 Jan; 30():115-21. PubMed ID: 25462180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.
    Sullivan SG; Feng S; Cowling BJ
    Expert Rev Vaccines; 2014 Dec; 13(12):1571-91. PubMed ID: 25348015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Big Data Usage Patterns in the Health Care Domain: A Use Case Driven Approach Applied to the Assessment of Vaccination Benefits and Risks. Contribution of the IMIA Primary Healthcare Working Group.
    Liyanage H; de Lusignan S; Liaw ST; Kuziemsky CE; Mold F; Krause P; Fleming D; Jones S
    Yearb Med Inform; 2014 Aug; 9(1):27-35. PubMed ID: 25123718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.